Cluster-Randomized Trial to Evaluate a Centralized Clinical Pharmacy Service in Private Family Medicine Offices

Circulation: Cardiovascular Quality and Outcomes

Volumn 11, Issue 6, 2018, Pages

  Carter, Barry L ^a   Levy, Barcey ^b   Gryzlak, Brian ^a   Xu, Yinghui ^b   Chrischilles, Elizabeth ^c   Dawson, Jeffrey ^c,e   Vander Weg, Mark ^b,d   Christensen, Alan ^b,d   James, Paul ^f   Polgreen, Linnea ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c The University of Georgia s College of Public Health   (United States)

^d Department of Communication Sciences and Disorders   (United States)

^e Veterans Administration   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular diseases; diabetes mellitus; guideline adherence; risk factors

Indexed keywords

HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL PHARMACY; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY MEDICINE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTOCOL COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; AGED; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CLUSTER ANALYSIS; FEMALE; HOSPITAL MANAGEMENT; HOSPITAL PHARMACY; INTEGRATED HEALTH CARE SYSTEM; IOWA; MALE; MIDDLE AGED; MULTICENTER STUDY; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PHARMACIST; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIMARY HEALTH CARE; PRIVATE PRACTICE; RISK FACTOR; TELECONSULTATION; TIME FACTOR; TREATMENT OUTCOME;

AGED; CARDIOVASCULAR DISEASES; CENTRALIZED HOSPITAL SERVICES; CLUSTER ANALYSIS; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; GUIDELINE ADHERENCE; HUMANS; IOWA; MALE; MIDDLE AGED; MODELS, ORGANIZATIONAL; PATIENT CARE TEAM; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; PREVENTIVE HEALTH SERVICES; PRIMARY HEALTH CARE; PRIVATE PRACTICE; PROSPECTIVE STUDIES; REMOTE CONSULTATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85053937595     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.117.004188     Document Type: Article

References (41)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011 123 e18 e209. doi: 10.1161/CIR.0b013e3182009701.
2. Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, Pettitt D, Kerr EA, Selby JV, Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med 2006 144 475 484
3. Higashi T, Shekelle PG, Solomon DH, Knight EL, Roth C, Chang JT, Kamberg CJ, MacLean CH, Young RT, Adams J, Reuben DB, Avorn J, Wenger NS, The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 2004 140 714 720
4. Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G, Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med 2011 171 1441 1453. doi: 10.1001/archinternmed.2011.399.
5. Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L, Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev 2010 CD000336. doi: 10.1002/14651858.CD000336.pub2.
6. Barnett MJ, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P, Halterman T, Perry PJ, Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm 2009 15 18 31. doi: 10.18553/jmcp.2009.15.1.18.
7. McCall N, Cromwell J, Results of the Medicare Health Support disease-management pilot program. N Engl J Med 2011 365 1704 1712. doi: 10.1056/NEJMsa1011785.
8. Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR, Chrischilles EA, Franciscus CL, Xu Y, Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009 169 1996 2002. doi: 10.1001/archinternmed.2009.358.
9. Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, Egan B, Vander Weg M, Chrischilles E, Vaughn T, Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes 2015 8 235 243. doi: 10.1161/CIRCOUTCOMES.114.001283.
10. Gums TH, Uribe L, Vander Weg MW, James P, Coffey C, Carter BL, Pharmacist intervention for blood pressure control: medication intensification and adherence. J Am Soc Hypertens 2015 9 569 578. doi: 10.1016/j.jash.2015.05.005.
11. Smith SM, Carris NW, Dietrich E, Gums JG, Uribe L, Coffey CS, Gums TH, Carter BL, Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension. J Am Soc Hypertens 2016 10 307 317. doi: 10.1016/j.jash.2016.01.010.
12. Bufalino V, Bauman MA, Shubrook JH, Balch AJ, Boone C, Vennum K, Bradley S, Wender RC, Minners R, Arnett D, American Cancer Society; American Diabetes Association; American Heart Association Evolution of "the guideline advantage": lessons learned from the front lines of outpatient performance measurement. Circ Cardiovasc Qual Outcomes 2014 7 493 498. doi: 10.1161/HCQ.0000000000000003.
13. Chan PS, Oetgen WJ, Buchanan D, Mitchell K, Fiocchi FF, Tang F, Jones PG, Breeding T, Thrutchley D, Rumsfeld JS, Spertus JA, Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry's PINNACLE (Practice Innovation And Clinical Excellence) program. J Am Coll Cardiol 2010 56 8 14. doi: 10.1016/j.jacc.2010.03.043.
14. Carter BL, Levy BT, Gryzlak B, Chrischilles EA, Vander Weg MW, Christensen AJ, James PA, Moss CA, Parker CP, Gums T, Finkelstein RJ, Xu Y, Dawson JD, Polgreen LA, A centralized cardiovascular risk service to improve guideline adherence in private primary care offices. Contemp Clin Trials 2015 43 25 32. doi: 10.1016/j.cct.2015.04.014.
15. BioLINCC. https://biolincc.nhlbi.nih.gov/home/. Accessed April 22, 2018
16. Tunis SR, Stryer DB, Clancy CM, Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003 290 1624 1632. doi: 10.1001/jama.290.12.1624.
17. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ, Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005 45 142 161. doi: 10.1161/01.HYP.0000150859.47929.8e.
18. Carter BL, Ardery G, Avoiding pitfalls with implementation of randomized controlled multicenter trials: strategies to achieve milestones. J Am Heart Assoc 2016 5 e004432. doi: 10.1161/JAHA.116.004432.
19. Carter BL, Clarke W, Ardery G, Weber CA, James PA, Vander Weg M, Chrischilles EA, Vaughn T, Egan BM, Collaboration Among Pharmacists Physicians To Improve Outcomes Now (CAPTION) Trial Investigators A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes 2010 3 418 423. doi: 10.1161/CIRCOUTCOMES.109.908038.
20. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, Carrell D, Tyll L, Larson EB, Thompson RS, Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA 2008 299 2857 2867. doi: 10.1001/jama.299.24.2857.
21. Shah BR, Adams M, Peterson ED, Powers B, Oddone EZ, Royal K, McCant F, Grambow SC, Lindquist J, Bosworth HB, Secondary Prevention Risk Interventions via Telemedicine and Tailored Patient Education (SPRITE): a randomized trial to improve postmyocardial infarction management. Circ Cardiovasc Qual Outcomes 2011 4 235 242. doi: 10.1161/CIRCOUTCOMES.110.951160.
22. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA, AHA/ACC; National Heart, Lung, and Blood Institute AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006 113 2363 2372. doi: 10.1161/CIRCULATIONAHA.106.174516.
23. Standards of medical care in diabetes-2008. Diabetes Care 2008 31 suppl 1 S12 S54
24. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 129 25 suppl 2 S1 S45. doi: 10.1161/01.cir.0000437738.63853.7a.
25. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E, 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014 311 507 520. doi: 10.1001/jama.2013.284427.
26. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL, American Heart Association/American Stroke Association Stroke Council; Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; Quality of Care and Outcomes Research Interdisciplinary Working Group; American Academy of Neurology Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006 37 1583 1633. doi: 10.1161/01.STR.0000223048.70103.F1.
27. Williams MA, Fleg JL, Ades PA, Chaitman BR, Miller NH, Mohiuddin SM, Ockene IS, Taylor CB, Wenger NK, American Heart Association Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or =75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2002 105 1735 1743
28. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T, American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006 37 577 617. doi: 10.1161/01.STR.0000199147.30016.74.
29. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ, National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004 110 227 239. doi: 10.1161/01.CIR.0000133317.49796.0E.
30. Taveira TH, Wu WC, Martin OJ, Schleinitz MD, Friedmann P, Sharma SC, Pharmacist-led cardiac risk reduction model. Prev Cardiol 2006 9 202 208
31. Bove AA, Santamore WP, Homko C, Kashem A, Cross R, McConnell TR, Shirk G, Menapace F, Reducing cardiovascular disease risk in medically underserved urban and rural communities. Am Heart J 2011 161 351 359. doi: 10.1016/j.ahj.2010.11.008.
32. Ma J, Berra K, Haskell WL, Klieman L, Hyde S, Smith MW, Xiao L, Stafford RS, Case management to reduce risk of cardiovascular disease in a county health care system. Arch Intern Med 2009 169 1988 1995. doi: 10.1001/archinternmed.2009.381.
33. Hoth AB, Carter BL, Ness J, Bhattacharyya A, Shorr RI, Rosenthal GE, Kaboli PJ, Development and reliability testing of the clinical pharmacist recommendation taxonomy. Pharmacotherapy 2007 27 639 646. doi: 10.1592/phco.27.5.639.
34. Carter BL, Bergus GR, Dawson JD, Farris KB, Doucette WR, Chrischilles EA, Hartz AJ, A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich) 2008 10 260 271
35. Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, Kerby TJ, Klotzle KJ, Maciosek MV, Michels RD, O'Connor PJ, Pritchard RA, Sekenski JL, Sperl-Hillen JM, Trower NK, Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA 2013 310 46 56. doi: 10.1001/jama.2013.6549.
36. Currell R, Urquhart C, Wainwright P, Lewis R, Telemedicine versus face to face patient care: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000 CD002098
37. Campbell MK, Fayers PM, Grimshaw JM, Determinants of the intracluster correlation coefficient in cluster randomized trials: the case of implementation research. Clin Trials 2005 2 99 107. doi: 10.1191/1740774505cn071oa.
38. Eapen ZJ, Liang L, Shubrook JH, Bauman MA, Bufalino VJ, Bhatt DL, Peterson ED, Hernandez AF, Current quality of cardiovascular prevention for Million Hearts: an analysis of 147,038 outpatients from the Guideline Advantage. Am Heart J 2014 168 398 404
39. Coronary Heart Disease Risk Calculator. http://www.medcalc.com/heartrisk.html. Accessed January 8, 2018
40. Tsuyuki RT, Al Hamarneh YN, Jones CA, Hemmelgarn BR, The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial. J Am Coll Cardiol 2016 67 2846 2854. doi: 10.1016/j.jacc.2016.03.528.
41. Yang R, Carter BL, Gums TH, Gryzlak BM, Xu Y, Levy BT, Selection bias and subject refusal in a cluster-randomized controlled trial. BMC Med Res Methodol 2017 17 94. doi: 10.1186/s12874-017-0368-7.